Advanced Search

 

Study ID Status Title Patient Level Data
29060/028/184 Completed An Interim Report to Assess the Efficacy and Tolerability of Paroxetine by Double-Blind Comparison with Amitriptyline in Patients Referred to a Psychiatric Clinic
29060/029 Completed An Assessment of the Efficacy and Tolerability of Paroxetine by Double-Blind Comparison with Amitriptyline in Patients Referred to a Psychiatric Clinic.
29060/03/001 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/002 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/003 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients
29060/03/004 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/005 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/006 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/019 Completed Assessment of the efficacy and tolerability of paroxetine by double blind comparison with amitriptyline in depressed patients
29060/030 Completed An Assessment of the Efficacy and Tolerability of Paroxetine by Double Blind Comparison with Mianserin in Patients Referred to a Psychiatric Clinic
29060/032 Completed A Double Blind Study to Compare the Efficacy and Tolerability of Paroxetine and Amitriptyline in a Multi-Centre General Practice Study in Depressed Patients
29060/033 Completed An Examination of Paroxetine and Other Antidepressants Alone and in Combination with Alcohol, on Car Driving and Psychomotor performance.
29060/034 Completed A Study to Assess the Efficacy and Tolerability of Paroxetine in Epileptic Patients with Depression
29060/035 Completed A Double-Blind Study to Assess the Efficacy and Tolerance of Paroxetine in Comparison with Amitriptyline in the Treatment of Depression
29060/037 Completed The Short Term Phase of an Open, Long-Term, Safety and Tolerability Study of Paroxetine in Patients Suffering from Depression
29060/038 Completed To Assess the Effectiveness and Tolerance of Paroxetine in Depressed Patients by Double Blind Comparison with Mianserin
29060/040 Completed Clinical aspects of a study to investigate the pharmacokinetics of paroxetine in elderly depressed patients
29060/041 Completed A Study to Assess the Efficacy and Tolerability of Paroxetine by Double-Blind Comparison of Morning and Evening Dosages
29060/042 Completed A Study to Assess the Efficacy and Tolerability of Paroxetine by Double-Blind Comparison of Morning and Evening Doses in the Elderly.
29060/043 Completed An Interim Report of a Study to Assess the Effectiveness and Tolerance of Paroxetine in Depressed Patients by Double-Blind Comparison with Amitriptyline (A follow-up final report was not prepared and is not expected for this study).
29060/044 Completed A Double-blind Comparative Two-centre Study to Assess the Efficacy and Tolerability of Paroxetine (20mg vs 30mg) in Elderly Depressed Patients
29060/046 Completed A Study to Assess the Efficacy and Tolerance of Paroxetine in Elderly Depressed Patients by Double-Blind Comparison with Amitriptyline
29060/048 Completed A study to assess the interaction of paroxetine with digoxin in normal healthy volunteers
29060/049 Completed A Multi-Centre General Practice Study to Compare the Effectiveness and Tolerability of Paroxetine in Elderly Depressed Patients by Double Blind Comparison with Amitriptyline
29060/051 Completed A study to compare the bioequivalence of two formulations of paroxetine, a 30 mg tablet and 3 x10 mg capsules

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.